Marketing authorisation and pricing of FDA-approved cancer drugs in Brazil: a retrospective analysis
巴西FDA批准的抗癌药物的上市许可和定价：一项回顾性分析
期刊:Lancet Regional Health-Americas
影响因子:7.6
doi:10.1016/j.lana.2023.100506
Ivama-Brummell, Adriana M; Marciniuk, Fernanda L; Wagner, Anita K; Osorio-de-Castro, Claudia G S; Vogler, Sabine; Mossialos, Elias; Tavares-de-Andrade, Carla L; Naci, Huseyin
